USPTO serial 72252527
BETALOC
Reviewed by CopyMark Law Group
Reg. 0831725Status 900
- Filing date
- Status date
- Registration date
- Jul 11, 1967
- Examiner
- —
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BETALOC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Wm. Charles Saunders
Wm. Charles Saunders AstraZeneca Pharmaceuticals LP1800 Concord PikeOW2Wilmington, DE 19850Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 018 | BETA-RECEPTOR- [ BLOCKING AGENTS ] * BLOCKERS FOR THE TREATMENT OF ANGINA PECTORIS AND OTHER CARDIOVASCULAR DISEASES * | EXPIRED | Jul 11, 1966 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 19, 2008 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Jul 23, 2007 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 23, 2007 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 11, 1987 | REN1 | REGISTERED AND RENEWED (FIRST RENEWAL - 20 YRS) | — |
| Feb 2, 1987 | 9.AF | REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8 | — |